Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 2, 1998, Pages 135-140

  Cullen, D ^a   Bardhan, K D ^b   Eisner, M ^c   Kogut, D G ^d   Peacock, R A ^e   Thomson, J M ^e   Hawkey, C J ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^c Zephyrhills Medical Center   (United States)

^d Priedmont Gastroenterology   (United States)

^e Astra Clinical Research Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; FAMOTIDINE; INDOMETACIN; MISOPROSTOL; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PIROXICAM; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; ENDOSCOPY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EROSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DUODENAL ULCER; DYSPEPSIA; FEMALE; FRANCE; GREAT BRITAIN; HUMANS; HUNGARY; IRELAND; LOGISTIC MODELS; MALE; MIDDLE AGED; OMEPRAZOLE; STOMACH ULCER; UNITED STATES;

EID: 0031975071     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00288.x     Document Type: Article

References (30)

1. Hawkey CJ. Non-steroidal anti-inflammatory drugs and ulcer: Facts and figures multiply, but do they add up? Br Med J 1990; 300: 278-84.
2. Fries JF, Miller SR, Spitz PW, et al. Toward an epidemiology of gastropathy associated with non-steroidal anti-inflammatory drug use. Gastroenterology 1989; 96: 647-55.
3. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
4. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
5. Committee on Safety of Medicines. Non steroidal anti inflammatory drugs and serious gastrointestinal adverse reactions. Br Med J 1986; 292: 1190-2.
6. Fries JF, Williams CA, Bloch DA, et al. Non steroidal anti inflammatory drug associated gastropathy: incidence and risk factor models. Am J Med 1991; 91: 213-22.
7. Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 18: 6-10.
8. Paulus HE. FDA arthritis advisor committee meeting: serious gastrointestinal toxicity of non-steroidal anti-inflammatory drugs, etc. Arthritis Rheum 1988; 31: 1450-1.
9. OPCS. Mortality Statistics by Cause, England and Wales, Series No. 20 (1993). London: HMSO, 1995.
10. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non steroidal anti-inflammatory drugs. Ann Intern Med 1995; 123: 241-9.
11. Walt RP. Misoprostol for the treatment of peptic ulcer and anti inflammatory drug induced gastroduodenal ulceration. N Engl J Med 1992; 327: 1575-80.
12. Ehsanullah RSB, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 1988; 297: 1017-20.
13. Robinson MG, Griffin JW Jr, Bowers J, et al. Effect of ranitidine on gastroduodenal mucosal damage induced by non-steroidal anti-inflammatory drugs. Dig Dis Sci 1989; 34: 424-8.
14. Daneshmend TK, Prichard PJ, Bhaskar NK, Millns P, Hawkey CJ. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine. Gastroenterology 1989; 97: 944-9.
15. Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ. Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut 1990; 31: 514-7.
16. Bigard MA, Isal JP. Prevention of aspirin induced gastric lesions by omeprazole in healthy subjects. Gastroenterology 1989; 96: A44.
17. Oddsson E, Gudjonsson H, Thjodleifsson B. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Scand J Gastroenterol 1992; 27: 1045-8.
18. Bianchi Porro G, Santalucia F, Petrillo M, Montrone F, Caruso I. Omeprazole vs placebo in the treatment of NSAID induced gastro duodenal ulcer. Gut 1996; 39 (1): 22-6.
19. Scheiman JM, Behler EM, Loeffler KM, Elta GH. Omeprazole ameliorates aspirin induced gastroduodenal injury. Dig Dis Sci 1994; 39: 97-103.
20. Taha A, Hudson N, Hawkey CJ, et al. Famotidine for prevention of gastric and duodenal ulcers caused by non steroidal anti inflammatory drugs. N Engl J Med 1996; 334: 1435-9.
21. Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcers. N Engl J Med 1989; 320: 69-75.
22. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: A population based study. Gastroenterology 1992; 102: 1259-68.
23. Penston JG, Wormsley KG. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Aliment Pharmacol Ther 1992; 6: 629-45.
24. Jensen DM, Cheng S, Kovacs TOG, et al. A controlled study of ranitidine for the prevention of recurrent haemorrhage from duodenal ulcer. N Eng J Med 1994; 330: 382-6.
25. Bardhan KD, Bjarnason I, Scott DL, et al. The prevention and healing of acute non steroidal anti inflammatory drug associated gastroduodenal mucosal damage by misoprostol. Br J Rheum 1993; 32: 990-5.
26. Jensen DM, You S, Pelayo E, Jensen ME. The prevalence of Helicobacter pylori and NSAID use in patients with severe UGI haemorrhage and their potential role in recurrence of ulcer bleeding. Gastroenterology 1992; 102: A90.
27. Reinbach DH, Cruickshank G, McColl KEL. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1995; 34: 1344-7.
28. Cullen DJE, Hawkey GM, Greenwood DC, et al. Peptic ulcer bleeding: Relative roles of Helicobacter pylori and non steroidal anti inflammatory drugs. Gut 1997; 41: 459-62.
29. Hawkey CJ, Swannel AJ, Yeomans ND, et al. Site specific ulcer relapse in non-steroidal anti-inflammatory drug (NSAID) users: Improved prognosis with H. pylori and with omeprazole compared to misoprostol. Gut 1996; 39: A149.
30. Hawkey CJ, Swannel AJ, Yeomans ND, et al. Increased effectiveness of omeprazole compared to ranitidine in non-steroidal anti-inflammatory drug (NSAID) users with reference to H. pylori status. Gut 1996; 39: A33.